The confluence of personalised medicine and the digital information age means that a much greater volume of information is required by physicians in successfully treating patients.
The pharma industry of today understands that good real-world patient outcomes can carry as much weight as robust regulatory data, so understanding drug use beyond the clinical trial setting is
Pharma is recognising the increasing importance of the patient voice in providing feedback on how medicines are utilised in a real-world setting and the impact they are having on outcomes.